| abstract |
The present invention relates to an antibody-binding recombinant fusion protein and an antibody-drug conjugate using the same, wherein the recombinant fusion protein consists of a secretory peptide, an albumin binding domain, and an antibody binding domain In addition, since it contains an albumin-binding domain, it can be comprehensively applied to albumin-based nanocarriers, including Abraxane, so that it is possible to produce antibody-drug conjugates without chemical bonding, such as albumin nanoparticles for delivering various drugs. It can be used as an applicable ADC platform technology. |